Valuation Clinuvel Pharmaceuticals Limited Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate Other stock markets 11:10:17 2026-06-19 EDT			5-day change	1st Jan Change
6.369 ^EUR	+9.81%		+14.50%	-14.29%

06-15	Clinuvel Pharmaceuticals Advances US Listing Plan With SEC Filing for Nasdaq ADS Upgrade	MT
04-27	Clinuvel Pharmaceuticals plans level II ADR upgrade and Nasdaq listing as CUVL	RE

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,517	733.7	883.5	769.8	520.3	519.4	-	-
Change	-	-51.63%	20.4%	-12.87%	-32.41%	-0.17%	-	-
Enterprise Value (EV) ¹	1,434	612.2	726.6	585.9	296.2	265.7	233.4	191.8
Change	-	-57.31%	18.69%	-19.37%	-49.45%	-10.29%	-12.17%	-17.82%
P/E	63.4x	36.8x	30.3x	22x	14.5x	13.9x	13.1x	10x
PBR	15.4x	5.84x	5.37x	3.79x	2.17x	1.82x	1.63x	1.4x
PEG	-	-2.2x	0.6x	1.2x	5.06x	-17.6x	2.02x	0.3x
Capitalization / Revenue	31.6x	11.2x	11.3x	8.73x	5.48x	5.22x	4.93x	3.93x
EV / Revenue	29.9x	9.32x	9.28x	6.64x	3.12x	2.67x	2.22x	1.45x
EV / EBITDA	55x	16.4x	19.5x	12x	6.84x	6.36x	5.25x	3.92x
EV / EBIT	56.8x	16.7x	20x	12.3x	7.03x	6.59x	5.37x	3.39x
EV / FCF	77.9x	15.5x	20.2x	18.6x	7.26x	8.4x	6.41x	3.43x
FCF Yield	1.28%	6.44%	4.94%	5.37%	13.8%	11.9%	15.6%	29.2%
Dividend per Share ²	0.025	0.04	0.05	0.05	0.05	0.0611	0.08	0.2257
Rate of return	0.08%	0.27%	0.28%	0.33%	0.48%	0.62%	0.81%	2.27%
EPS ²	0.484	0.403	0.591	0.698	0.718	0.7123	0.7585	0.9888
Distribution rate	5.17%	9.93%	8.46%	7.16%	6.96%	8.58%	10.5%	22.8%
Net sales ¹	47.98	65.72	78.32	88.18	95.02	99.46	105.4	132.1
EBITDA ¹	26.1	37.44	37.2	48.95	43.3	41.75	44.47	48.93
EBIT ¹	25.24	36.68	36.41	47.81	42.12	40.34	43.44	56.59
Net income ¹	24.73	20.88	30.6	35.64	36.17	35.97	38.2	49.83
Net Debt ¹	-82.69	-121.5	-156.8	-183.9	-224.1	-253.7	-286	-327.6
Reference price ²	30.700	14.850	17.880	15.370	10.380	9.930	9.930	9.930
Nbr of stocks (in thousands)	49,410	49,410	49,410	50,083	50,124	50,428	-	-
Announcement Date	8/26/21	8/30/22	8/29/23	8/28/24	8/27/25	-	-	-

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	15.79x	3.41x	9.2x	0.64%	62.05B
UCB	26.86x	5.43x	15.89x	0.59%	54.45B
SAMSUNG BIOLOGICS CO.,LTD.	35.35x	11.98x	22.6x	-.--%	43.09B
CSL LIMITED	-48.84x	2.94x	8.68x	3.75%	36.37B
BIOGEN INC.	31.74x	3.42x	10.51x	-.--%	29.02B
MODERNA, INC.	-7.4x	10.42x	-6.37x	-.--%	25.38B
INCYTE CORPORATION	14.83x	2.6x	8.05x	-.--%	19.62B
INNOVENT BIOLOGICS, INC.	47.72x	5.2x	36.07x	-.--%	16.89B
SWEDISH ORPHAN BIOVITRUM AB	24.64x	5.1x	13.75x	-.--%	15.93B
Average	15.63x	5.61x	13.15x	0.55%	33.64B
Weighted average by Cap.	14.57x	5.66x	12.73x	0.69%